Lynette Hopkinson
Keine laufenden Positionen mehr
Profil
Lynette Hopkinson worked as the VP & Head-Cystic Fibrosis Regulatory Strategy at Vertex Pharmaceuticals, Inc. from 2014 to 2020.
She then worked as the Senior Vice President-Regulatory at Imara, Inc. from 2020 to 2021.
Prior to her career, she completed her undergraduate degree at the University of the Witwatersrand.
Ehemalige bekannte Positionen von Lynette Hopkinson
| Unternehmen | Position | Ende |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 01.09.2020 |
| IMARA | General Counsel | - |
Ausbildung von Lynette Hopkinson
| University of the Witwatersrand | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
